南通100一次(南通矿业开创一次捷径)

2024-04-26 03:06:49 | 来源:适应新闻网
小字号

南通100一次(南通矿业开创一次捷径)

南通市位于江苏省东部沿海地区,拥有丰富的矿产资源和良好的开发条件。南通市矿业局近日宣布,他们拟推出一项名为“南通100一次”的矿业开发计划,旨在为南通地区的矿业开发提供一种全新的捷径,进一步推动地方经济的发展。

作为江苏省矿业资源最为丰富的城市之一,南通市的矿产资源潜力巨大。然而,长期以来,由于开发难度大、投资回报周期长等原因,南通市的矿业开发一直受到了限制。面对这一局面,南通市矿业局决定采取一系列措施,推出“南通100一次”计划,力求为矿业开发提供更加便捷、高效的解决方案。

“南通100一次”计划的核心理念是一次性解决矿业开发问题。传统的矿业开发模式往往需要通过几个阶段逐步开发矿产资源,包括申请开采许可、矿产资源评估、环境评估等。而“南通100一次”计划则通过简化流程、整合资源,将这些繁琐的程序集中在一次性申请中完成,大大缩短了矿业开发的周期。

此外,“南通100一次”计划还将充分利用新的科技手段,加快矿业开发的进程。通过应用无人机、遥感技术等先进装备,对矿产资源进行精准勘探,提高勘探效率。同时,借助大数据分析和人工智能技术,对开采方案进行优化,降低开采成本,提高经济效益。

南通市矿业局相关负责人表示,“南通100一次”计划的实施将彻底改变传统的矿业开发模式,为南通地区的矿业开发注入新的活力。该计划将提升南通市的矿业开发水平,加快推进相关产业链的发展,为地方经济增添新的动力。

总之,“南通100一次”计划的推出,将为南通市的矿业开发注入一股新的活力,提高矿业开发的效率和质量。相信随着这一计划的实施,南通市的矿业资源将得到更好的开发利用,为地方经济的发展做出更大贡献。


(责编:admin)

分享让更多人看到

 榆次大学城上门300元4个小时 (保险业服务:上门实施保险方案)

榆次大学城上门300元4个小时 (保险业服务:上门实施保险方案)

2024-04-26 03:11:50 | 来源:密码新闻网
小字号

榆次大学城上门300元4个小时 (保险业服务:上门实施保险方案)

随着人们对保险意识的提高,保险行业正迎来蓬勃发展的时代。在这个竞争激烈的市场中,保险公司为了满足客户需求,不断创新服务模式。榆次大学城上门300元4个小时的保险业服务正是一项新型服务,通过上门实施保险方案,为客户提供更便捷、贴心的保险服务。

1. 简介

榆次大学城上门300元4个小时的保险业服务是一种创新的服务模式,为客户提供上门实施保险方案的便利。常规的保险购买流程中,客户需要前往保险公司办理手续,填写表格等繁琐的程序,费时费力。而这项新型保险服务通过预约专业保险顾问上门,为客户提供全方位的保险咨询和购买服务,大幅度提高了购买保险的便捷性。

2. 服务内容

榆次大学城上门300元4个小时的保险业服务包括但不限于以下内容:

保险方案设计:根据客户需求和风险状况,专业保险顾问为客户量身定制保险方案。

保险产品介绍:专业保险顾问详细介绍各类保险产品,帮助客户选择适合自己的保险产品。

保费分析和预算:保险顾问通过综合客户经济状况,对保险费用进行分析和预算,帮助客户合理规划保险支出。

购买保险产品:保险顾问在现场为客户办理保险购买手续,确保交易安全快捷。

售后服务:购买保险后,保险顾问将提供长期的售后服务,解答客户疑问,处理理赔事宜等。

3. 服务优势

榆次大学城上门300元4个小时的保险业服务相比传统购买方式具有很多优势:

便捷高效:专业保险顾问上门服务,省去客户前往保险公司办理手续的麻烦,节省时间和精力。

个性化定制:保险顾问根据客户需求和风险状况,量身定制保险方案,提供个性化的保险服务。

专业咨询:保险顾问拥有丰富的保险知识和行业经验,能够为客户提供专业的咨询和建议。

安全可靠:购买保险时,保险顾问在现场为客户办理手续,确保交易安全可靠。

长期售后:购买保险后,保险顾问将提供长期的售后服务,为客户解答疑问,处理理赔等事宜。

4. 应用范围

榆次大学城上门300元4个小时的保险业服务适用于广泛的客户群体,特别适合以下情况:

繁忙人士:工作繁忙,无法抽出时间前往保险公司办理手续的人士。

老年人:年纪较大,行动不便,需要专人上门咨询和购买保险的老年人。

缺乏保险知识的人群:对保险产品了解较少,需要专业保险顾问的指导和帮助。

购买额外保险的人群:已有保险但希望购买额外保险的客户。

总之,榆次大学城上门300元4个小时的保险业服务为客户提供了更便捷、个性化的保险购买体验。这项服务的推出,不仅提升了保险购买的便利性,也为更多人提供了全面的保险保障。无论是繁忙的上班族还是需要特别关注保险的老年人,都能够享受到这项专业化的服务。保险业务的创新将不断推动行业的发展,为广大客户提供更好的保险体验。


(责编:admin)

分享让更多人看到

Asia Cell & Gene Therapy Innovation Summit 2024
  • Apr. 2nd - 3rd 2024
  • Shanghai, China

CGT Asia 2024 - The 5th Asia Cell & Gene Therapy Innovation Summit 2024
3DCC 2024 - The 2nd 3D Cell Culture and Organoid R&D Summit
CGT Awards - 2024 Asia Pacific Cell and Gene Therapy Innovation Star of the Year Award

0 +

Keynote
Speeches

0 +

Professional
Attendees

0 +

Featured
Booths

0 +

Global Cell&Gene
Therapy Enterprises

0 +

Media
Reports

Key words of the conference

Commercialization and Innovative Drug Access to Hospitals, Clinically Oriented and Innovative Therapies, Stem Cell Therapy, Extracellular Vesicles Therapy, MSC EV, Cell Therapy, Gene Therapy, RNA Therapy, Oncolytic Virus, Rare Disease, Tumor Microenvironment, Non-coding RNAs, Epigenetic, Single-Cell Sequencing, Biomarkers, Universal Cancer only Maker (UCOM), Immune Cell, TCR-T, CAR-NK, 3D Cell Culture, Organoid Model, CRISPR/CAS9 Gene Editing, iPSC, PCR, High-Throughput Screening, Application Plans,Continuous Production Process, GMP, AAV, (Non-) Viral Vectors, LNP etc.

Chips-on-Organoid, Microfluidic Technology, 3D Bio-Printing,Organoid vascularization, Advances in Cutting-Edge Technologies, Standardization and Application Scenarios, Clinical Research Applications, Drug Sensitivity Screening, R&D Applications, Efficacy Study, Cross-Cutting Technologies, Regenerative Medicine, Discussions on Laws and Regulations, etc.

Topics Highlights
The 5th Asia Cell and Gene Therapy Innovation Summit 2024
  • Case Study of Marketed Targeting CD19 CAR-T Cell Therapy Clinical Trials

  • Progress of Clinical Research on Mesenchymal Stem Cell Therapy for End-Stage Liver Disease

  • Highlights of Before and After Marketing Changes for Cell Therapy Drugs

  • Top CDMO Takes Your Cell Culture from Customization to Global Standardization

  • Role and Mechanisms of Cardiac-Derived Exosomes in Oncological Cardio Therapy

  • Bring In or Going Overseas--How to Accelerate the Commercialization of Cell Therapy?

  • Recent Clinical Advances in Gene Therapy for Hereditary Deafness

  • Novel Malignant Tumor Therapeutic Strategy - Lysovirus Enhances The Anti-Tumor

    Effect of DC Vaccines

  • Efficient Dual AAV Carrier Development Optimization and Design

  • Application and Progress of Small Nucleic Acid Drugs in The Field of Chronic Diseases

    such as Cardiovascular Diseases

  • ......

2024 3D Cell Culture Organoid R&D Summit

  • Regenerative Medicine Through The Eyes of An Investor

  • Microfluidic Chip-Assisted Vascularisation of Human Brain Organoids

  • Construction of Novel Human Endometrial Organoids

  • Research on Human Bionic Organoid and Organ-on-a-Chip Based on Neural Innervation

  • Clinical Case Sharing of Heart Transplantation for Heart Failure

  • Quality Control of Organoid Drug Sensitivity Testing Throughout the Entire Process

  • ......


At a Glance

3-2312121626223a.png


3-231120145302209.png

Exhibition & Show
Exhibition & Show
Exhibition & Show
Exhibition & Show
Exhibition & Show
Exhibition & Show
Exhibition & Show


Part of Speakers

Prof. Xinhua LIN
Prof. Xinhua LIN

President

School of Life Sciences Fudan University /  Greater Bay Area Institute of Precision Medicine

Prof. Zibing JIN
Prof. Zibing JIN

Deputy President of Beijing Tongren Hospital

Beijing Tongren Hospital Capital Medical University, Beijing Institute of Ophthalmology

Prof. Cheng QIAN
Prof. Cheng QIAN

CSO

Precision Biotech

Prof. Wei ZUO
Prof. Wei ZUO

Chairman

Regend Therapeutics

Prof. Hao SHEN
Prof. Hao SHEN

CSO

FOSUNKite

Dr. Maryland Franklin
Dr. Maryland Franklin

VP

Labcorp

Dr. Aron  JAFFE
Dr. Aron JAFFE

SVP

Chroma Medicine

Prof. Jonathan  Yuin-Han LOH
Prof. Jonathan Yuin-Han LOH

Director

A*STAR IMCB

Dr. Noriyasu ISHIKAWA
Dr. Noriyasu ISHIKAWA

CEO

Solallis Bio Inc.

Dr. David DU
Dr. David DU

Co-founder, CEO

Evergreen Therapeutics

Prof. Hongming HU
Prof. Hongming HU

CSO

ImmuXell

Prof. Guoying ZHOU
Prof. Guoying ZHOU

Chairman & CEO

ImmVira

Dr. Joan SHEN
Dr. Joan SHEN

Founder & CEO

NeuShen Tx

prof. Wenbin Qian
prof. Wenbin Qian

Founder

Rongu bio

Dr. Cecilia ZHANG
Dr. Cecilia ZHANG

CSO

Biosyngen

Mrs. Lanlin WU
Mrs. Lanlin WU

CEO

Carcell Biopharma Ltd.

Dr. Baohong ZHANG
Dr. Baohong ZHANG

CEO

Epigenic Therapeutics, Inc.

Dr. Minmin SUN
Dr. Minmin SUN

Chairman & CEO

Immunofoco

Prof. Alex H. Chang
Prof. Alex H. Chang

CEO

YaKe Biotech

Dr. Huashun LI
Dr. Huashun LI

Chairman

Ascle Therapeutics

Mr. Zhenhua Luo
Mr. Zhenhua Luo

PI

The First Affiliated Hospital of Sun Yat-sen University

Prof. Peng LIU
Prof. Peng LIU

Prof

Tsinghua university

Dr. Adam ZHAO
Dr. Adam ZHAO

Founder

Anlongbio

Dr. Binghe TAN
Dr. Binghe TAN

Co-Partner, Vice President of Production and CMC

BRL Medicine Inc.

Prof. Guoqiang HUA
Prof. Guoqiang HUA

Founder of D1 Medical

D1 MEDICAL TECHNOLOGY

Dr. Jun Li
Dr. Jun Li

CEO

Fundamentatx

Prof.  Bing Zhao
Prof. Bing Zhao

Prof

fudan university

Dr. Yuan CAI
Dr. Yuan CAI

CEO/Co-Founder

Starrygene Therapeutics

PI. Liang Li
PI. Liang Li

PI

southern medical university

Dr. Xiaofang Tang
Dr. Xiaofang Tang

Dr

GBA-IPM

Dr. Yi JIN
Dr. Yi JIN

CEO

GeCell Therapeutics

Mr. Zhihui Weng
Mr. Zhihui Weng

vp

sharecaptal

Dr. Libo ZHAO
Dr. Libo ZHAO

CTO

Echo Biotech

Dr. Andrew LIN
Dr. Andrew LIN

CEO

Lingyi Biotech Co., Ltd.

Dr. Yarong LIU
Dr. Yarong LIU

Founder/CEO

Grit Biotechnology

Dr. Wenmin ZHU
Dr. Wenmin ZHU

Marketing Director

T&L Biotechnology

Prof. Donghui ZHANG
Prof. Donghui ZHANG

Prof

Hubei university

Dr. Lang Zhang
Dr. Lang Zhang

Head of CMC-PD mRNA, in vivo Platform

CorrectSequence Therapeutics

Mr. Yun LIU
Mr. Yun LIU

Chairman/President

Huayi Capital/Huayi Research Institute

Dr. Yu ZHANG
Dr. Yu ZHANG

Founder/CEO

VCANBIO Life Science

Dr. ZhengBo SU
Dr. ZhengBo SU

Chairman

TCRCure Biopharma Ltd.

Dr. Junjie PENG
Dr. Junjie PENG

Chief Physician, Colorectal Surgery

Fudan University Shanghai Cancer Center

Dr. Ming YUAN
Dr. Ming YUAN

Chairman

Huayaokangming

Dr. Ying ZHANG
Dr. Ying ZHANG

Co-founder, CTO

Nuwacell

Dr. Xiang LI
Dr. Xiang LI

Chairman&Founder&CEO

XellSmart

Dr. Qiang CHEN
Dr. Qiang CHEN

CTO

DanausGT

Dr. Xueliang YU
Dr. Xueliang YU

VP

Starna Therapeutics

Mr. Gang LU
Mr. Gang LU

vp

shlifestemcell

Mrs. Zhong ZHAO
Mrs. Zhong ZHAO

BU Head & Chief Product Officer

DXY Insight Database

Dr. Wee Kiat TAN
Dr. Wee Kiat TAN

Co-CEO & COO

CytoMed Therapeutics

Dr. Xuedong DAI
Dr. Xuedong DAI

VP

collectively known as SAFE GLP

Mr. Victor YU
Mr. Victor YU

Country Manager of Greater China

Astrea Bioseparations Ltd

Dr. Lifan WEI
Dr. Lifan WEI

Senior Investigator

INADRD, CSPC

Dr. Zhou LI
Dr. Zhou LI

CSO

Juventas Cell Therapy LLC

Mr. Jack ZHANG
Mr. Jack ZHANG

Strategy and Business Development Lead, CGT APAC

Lonza

Dr. Zhao ZHU
Dr. Zhao ZHU

Co-founder/Chairman/CEO

Neuregen Therapeutics

Dr. Ramin BAGHIRZADE
Dr. Ramin BAGHIRZADE

Global Head Commercial – Gene Therapy CDMO Services

Charles River丨Biologics Solutions

Dr. Wenji DONG
Dr. Wenji DONG

Founder & Chairman

Genmedicn

Dr. Forrest CHEN
Dr. Forrest CHEN

CSO

Zhongying Biomedical

Dr. Gaofeng ZHA
Dr. Gaofeng ZHA

CEO

MagicRNA

Mrs. Wendy LIN
Mrs. Wendy LIN

Key Account Manager

EMBALL'ISO

 Mr.Gary Wang
Mr.Gary Wang

General Manager

kanglitai

Dr. Yang YANG
Dr. Yang YANG

CEO

Genevector Biotech

Dr. Jing FAN
Dr. Jing FAN

Founder & CEO

Hopstem

Mr. Zebin LING
Mr. Zebin LING

CEO

MingCeler

Dr. Ling PENG
Dr. Ling PENG

Medical Director

TCRcure

Prof. Hua LIU
Prof. Hua LIU

Founder, Chief Scientific Officer

Xinghua Bio

Dr. Fan MO
Dr. Fan MO

Co-founder & CEO

Neoantigen

Dr. Xinpo JIANG
Dr. Xinpo JIANG

Associate Vice President of R&D

GenScript

Mrs. Gloria Teng
Mrs. Gloria Teng

Executive Partne

GTJA Investment

Prof. Shuhang WANG
Prof. Shuhang WANG

Attending Doctor

CANCER HOSPITAL CHINESE ACADEMY OF MEDICAL SCIENCE

Mr. Alex CHENG
Mr. Alex CHENG

General Manager

Tofflon

Prof. Zhiyong ZHANG
Prof. Zhiyong ZHANG

Awardee of the First Prize of National Science and Technology Progress Award of China (Top scientific awards in China);Expert of National Talent Program of China;Chief Scientist of REGEN-αGEEK

REGEN-αGEEK

Dr. Luke LI
Dr. Luke LI

BD and Commercial VP

Neurophth Therapeutics

Mrs. Emily TAN
Mrs. Emily TAN

Chief Operating Officer

Unixell Biotechnology

Prof. Mi LIU
Prof. Mi LIU

Founder

Es-Bio

Dr. Hexige Saiyin
Dr. Hexige Saiyin

Assistant professor

Fudan University

Prof. Tianqing LI
Prof. Tianqing LI

Prof

Kunming University of Science and Technology

Dr. Zaozao CHEN
Dr. Zaozao CHEN

CTO

Avatarget

Mr. Chilin WU
Mr. Chilin WU

Partner

DeHeng

Prof. Jie LIU
Prof. Jie LIU

Principal scientist

Eacin Bio

Dr. Lei WANG
Dr. Lei WANG

Department Head of the Cell Resources Center of the National Stem Cell Resource Center

Institute of Zoology, Chinese Academy of Sciences/Beijing Institute of Stem Cell and Regenerative Medicine

Dr. Yi ZHOU
Dr. Yi ZHOU

COO

AimingMed

Prof. Hongju MAO
Prof. Hongju MAO

PI

Shanghai Institute of Microsystems and Information Technology, Chinese Academy of Sciences

Prof. Huaying CHEN
Prof. Huaying CHEN

Prof

Harbin Institute of Technology

Mrs. Katie LI
Mrs. Katie LI

Head of Clinical Operation

CorrectSequence Therapeutics

Dr. Yan XU
Dr. Yan XU

VP

Binhui Biopharm



More guests will continue to update them

Ways to Attend

Increase Your Visibility. Improve Your Reputation

Normal Ticket

  • 1 Pass

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs & Documentation


Exhibition Sponsor

  • 3 Passes

  • 6㎡or 9㎡ Booth for show

  • Holistic Logo Branding On-site

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs& Documentation


Presentation Sponsor

( Slots Limited)

  • 5 Passes

  • 30 min Speech Opportunity

  • 1 Color AD Page

  • Panelist Discussion

  • Holistic Logo Branding On-site

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs& Documentation


Gold Sponsor

(Exclusive)

  • 5 or More Passes

  • 30 min Speech Opportunity

  • 6or 9 Booth for show

  • Chairman Opportunity

  • 1 Color AD Page

  • Panelist Discussion

  • Holistic Logo Branding On-site

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs& Documentation


Secure your ticket today

Early Bird tickets available now

Secure your spot at CGT Asia our special offer, and don’t go alone, enjoy the best group discount.

Register

Sponsors & Partners

Part of Previous Sponsors

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
26

Part of Media Partners

今日头条
搜狐
药智网
医谷网
CPHI制药在线
会会药咖
镁客网
广动医谷
丁香会议
研发客
肽度
大健康派
生物探索
药源网
基因线上
转化医学网
现代健康网
医药健闻
中国制药设备网
细胞知聊
新康界
医诺医学
美通社
动脉网
医疗器械创新网
新浪医药
中国仪器批发网
细胞世界
戊戌数据
大健康网
嘉裕检测
肽研社
测序宝
基因君
猎药人
化学网
爱爱医
来宝网
生物咖啡茶
生物通
医学信息
中国生物器材网
分析测试百科网
全球医学会议网

Related Meetings

Presentation, Sponsorship and Exhibition

Gina Xu

Tel:86 21 5893 3801 ext.805

Mob:13601679417

Email:gina.xu@taaslabs.com

Media and Marketing Cooperation

Koala Yan

Tel:86 215893 3801 ext. 811

Mob:13341683667

Email:koala.yan@taaslabs.com

Know More Hot and informative Medical News on Biopharma, Cell& Gene etc. Follow Us Now